Pesquisadores do CEMO integram estudo que desvenda morte celular programada na Leucemia Mieloide Crônica

dc.TypeArticlept_BR
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva
dc.contributor.authorInstituto Nacional de Câncer (Brasil)
dc.contributor.authorINCA
dc.date.accessioned2022-07-18T14:07:26Z
dc.date.available2022-07-18T14:07:26Z
dc.date.issued2011-03
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9247
dc.subjectLeucemia Mielogênica Crônica BCR-ABL Positivapt_BR
dc.subjectLeukemia, Myelogenous, Chronic, BCR-ABL Positivept_BR
dc.subjectLeucemia Mielógena Crónica BCR-ABL Positivapt_BR
dc.subjectMétodospt_BR
dc.subjectMethodspt_BR
dc.titlePesquisadores do CEMO integram estudo que desvenda morte celular programada na Leucemia Mieloide Crônicapt_BR
dc.title.alternativeInforme INCA 286pt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Informe INCA 286-3.pdf
Size:
59.49 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections